372648004: Atypical antipsychotic (substance)

Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

1197942011 Atypical antipsychotic (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

1211175015 Atypical antipsychotic en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

4493621000005116 Atypisk antipsykotisk middel da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Atypisk antipsykotisk middel	Is a	Anti-psychotic agent (substance)	false	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Quetiapine fumarate	Is a	False	Atypisk antipsykotisk middel	Inferred relationship	Some
Norclozapine	Is a	False	Atypisk antipsykotisk middel	Inferred relationship	Some
Product containing olanzapine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Atypisk antipsykotisk middel	Inferred relationship	Some
Product containing quetiapine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Atypisk antipsykotisk middel	Inferred relationship	Some
Product containing sertindole (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Atypisk antipsykotisk middel	Inferred relationship	Some
Olanzapine 5 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Atypisk antipsykotisk middel	Inferred relationship	Some
Olanzapine 7.5 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Atypisk antipsykotisk middel	Inferred relationship	Some
Olanzapine 10 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Atypisk antipsykotisk middel	Inferred relationship	Some
Olanzapine 2.5 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Atypisk antipsykotisk middel	Inferred relationship	Some
Olanzapine 5 mg orodispersible tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Atypisk antipsykotisk middel	Inferred relationship	Some
Product containing precisely olanzapine 10 milligram/1 each conventional release orodispersible tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Atypisk antipsykotisk middel	Inferred relationship	Some
quetiapin 25 mg + 100 mg + 150 mg tablet, startpakning	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Atypisk antipsykotisk middel	Inferred relationship	Some
quetiapin 150 mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Atypisk antipsykotisk middel	Inferred relationship	Some
atypisk antipsykotisk middel	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Atypisk antipsykotisk middel	Inferred relationship	Some
Olanzapine 20 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Atypisk antipsykotisk middel	Inferred relationship	Some
Olanzapine 15 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Atypisk antipsykotisk middel	Inferred relationship	Some
Olanzapine 15mg disintergrating tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Atypisk antipsykotisk middel	Inferred relationship	Some
Olanzapine 20 mg orodispersible tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Atypisk antipsykotisk middel	Inferred relationship	Some
Olanzapine tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Atypisk antipsykotisk middel	Inferred relationship	Some
Olanzapine oral disintergrating tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Atypisk antipsykotisk middel	Inferred relationship	Some
Clozapine (substance)	Is a	False	Atypisk antipsykotisk middel	Inferred relationship	Some
Amisulpride	Is a	False	Atypisk antipsykotisk middel	Inferred relationship	Some
Zotepine (substance)	Is a	False	Atypisk antipsykotisk middel	Inferred relationship	Some
Product containing aripiprazole (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Atypisk antipsykotisk middel	Inferred relationship	Some
Aripiprazole 5 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Atypisk antipsykotisk middel	Inferred relationship	Some
Aripiprazole 10 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Atypisk antipsykotisk middel	Inferred relationship	Some
Aripiprazole 15 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Atypisk antipsykotisk middel	Inferred relationship	Some
Aripiprazole 20 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Atypisk antipsykotisk middel	Inferred relationship	Some
Aripiprazole 30 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Atypisk antipsykotisk middel	Inferred relationship	Some
Product containing precisely olanzapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Atypisk antipsykotisk middel	Inferred relationship	Some
Product containing fluoxetine and olanzapine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Atypisk antipsykotisk middel	Inferred relationship	Some
olanzapin 6 mg + fluoxetin 25 mg kapsel	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Atypisk antipsykotisk middel	Inferred relationship	Some
olanzapin 6 mg/fluoxetin 50 mg kapsel	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Atypisk antipsykotisk middel	Inferred relationship	Some
olanzapin 12 mg + fluoxetin 25 mg kapsel	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Atypisk antipsykotisk middel	Inferred relationship	Some
olanzapin 12 mg + fluoxetin 50 mg kapsel	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Atypisk antipsykotisk middel	Inferred relationship	Some
Olanzapine-containing product in parenteral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Atypisk antipsykotisk middel	Inferred relationship	Some
olanzapin 10 mg pulver til injektionsvæske	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Atypisk antipsykotisk middel	Inferred relationship	Some
Ziprasidone (substance)	Is a	False	Atypisk antipsykotisk middel	Inferred relationship	Some
Quetiapine (as quetiapine fumarate) 25 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Atypisk antipsykotisk middel	Inferred relationship	Some
Product containing precisely quetiapine (as quetiapine fumarate) 100 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Atypisk antipsykotisk middel	Inferred relationship	Some
Product containing precisely quetiapine (as quetiapine fumarate) 200 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Atypisk antipsykotisk middel	Inferred relationship	Some
Product containing precisely olanzapine 15 milligram/1 each conventional release orodispersible tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Atypisk antipsykotisk middel	Inferred relationship	Some
quetiapinfumarat 300 mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Atypisk antipsykotisk middel	Inferred relationship	Some
Product containing remoxipride (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Atypisk antipsykotisk middel	Inferred relationship	Some
Aripiprazole 1 mg/mL oral solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Atypisk antipsykotisk middel	Inferred relationship	Some
Remoxipride hydrochloride	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Atypisk antipsykotisk middel	Inferred relationship	Some
Sertindole (substance)	Is a	False	Atypisk antipsykotisk middel	Inferred relationship	Some
Aripiprazole 2 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Atypisk antipsykotisk middel	Inferred relationship	Some
Asenapine (substance)	Is a	False	Atypisk antipsykotisk middel	Inferred relationship	Some
Lurasidone (substance)	Is a	False	Atypisk antipsykotisk middel	Inferred relationship	Some
Pimavanserin (substance)	Is a	False	Atypisk antipsykotisk middel	Inferred relationship	Some

Reference Sets

Concept inactivation indicator reference set

REPLACED BY association reference set (foundation metadata concept)

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1197942011	Atypical antipsychotic (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1211175015	Atypical antipsychotic	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
4493621000005116	Atypisk antipsykotisk middel	da	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	Danish module (core metadata concept)